Literature DB >> 20427403

Role of CT colonography in colorectal cancer screening: risks and benefits.

Christian P Pox1, Wolff Schmiegel.   

Abstract

The purpose of this article is to review recent developments in the role of CT colonography with an emphasis on colorectal cancer screening. An introduction to the concept and method of CT colonography is given as well as a summary of the data on performance of CT colonography. Furthermore, details on side effects, efficacy and cost-effectiveness and the possible role of extracolonic findings are provided. The impact CTC could have on colonoscopy and other possible indications of the method are also mentioned.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20427403     DOI： 10.1136/gut.2009.183046

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  4 in total

1.  Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.

Authors:  Ji-Gui Chen; Juan Cai; Huan-Lei Wu; Hua Xu; Yu-Xing Zhang; Chao Chen; Qian Wang; Jun Xu; Xiang-Lin Yuan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

2.  Extracolonic findings at CT colonography in an oncological hospital setting and why they matter.

Authors:  John M Ward; Burcin Agridag Ucpinar; Maria Clara Fernandes; Junting Zheng; Marinela Capanu; Natalie Gangai; Marc J Gollub; Natally Horvat
Journal:  Clin Imaging       Date:  2022-03-29       Impact factor: 2.420

Review 3.  CT colonography for population screening of colorectal cancer: hints from European trials.

Authors:  Lapo Sali; Daniele Regge
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

4.  A multi-centre randomised double-blind placebo-controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT colonography.

Authors:  Thierry N Boellaard; Marije P van der Paardt; Markus W Hollmann; Susanne Eberl; Jan Peringa; Lex J Schouten; Giedre Kavaliauskiene; Jurgen H Runge; Jeroen A W Tielbeek; Jaap Stoker
Journal:  BMC Gastroenterol       Date:  2013-05-25       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.